OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
72
Results
Show all
Save search
Copy query
Show results for
Unknown
(72)
Publication Date
Release Date
2012
(12)
2014
(8)
2025
(7)
2015
(7)
2019
(6)
2013
(6)
2016
(4)
2011
(4)
2021
(3)
2018
(3)
2009
(3)
2023
(2)
2022
(2)
2020
(2)
2010
(2)
2008
(1)
Previous
page
1 / 8
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
8
Next
page
Sort
by:
Relevance
Page size
10
Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
Not available
S-EPMC5569692
|
biostudies-literature
Cite
Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
Not available
S-EPMC5569693
|
biostudies-literature
Cite
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.
Not available
S-EPMC3376394
|
biostudies-literature
Cite
Longitudinal Correlates of Health Risk Behaviors in Children and Adolescents with Type 2 Diabetes.
Not available
S-EPMC4414713
|
biostudies-literature
Cite
Intensive Weight Loss Intervention and Cancer Risk in Adults with Type 2 Diabetes: Analysis of the Look AHEAD Randomized Clinical Trial.
Not available
S-EPMC8855671
|
biostudies-literature
Cite
Weight Change During the Postintervention Follow-up of Look AHEAD.
Not available
S-EPMC9277114
|
biostudies-literature
Cite
The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in β-Cell Function in TODAY.
Not available
S-EPMC6300703
|
biostudies-literature
Cite
Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program.
Not available
S-EPMC4158711
|
biostudies-literature
Cite
Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study.
Not available
S-EPMC6429636
|
biostudies-literature
Cite
Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants.
Not available
S-EPMC3837047
|
biostudies-literature
Cite
Previous
page
1 / 8
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
8
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets